Royce & Associates LP lowered its position in Exponent, Inc. (NASDAQ:EXPO - Free Report) by 10.3% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 187,726 shares of the business services provider's stock after selling 21,442 shares during the quarter. Royce & Associates LP owned about 0.37% of Exponent worth $21,641,000 as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds have also recently added to or reduced their stakes in EXPO. Quarry LP acquired a new stake in Exponent in the second quarter worth about $25,000. GAMMA Investing LLC lifted its stake in shares of Exponent by 67.7% in the 2nd quarter. GAMMA Investing LLC now owns 379 shares of the business services provider's stock worth $36,000 after acquiring an additional 153 shares during the period. Whittier Trust Co. of Nevada Inc. boosted its holdings in shares of Exponent by 166.5% in the second quarter. Whittier Trust Co. of Nevada Inc. now owns 517 shares of the business services provider's stock valued at $49,000 after acquiring an additional 323 shares in the last quarter. USA Financial Formulas bought a new position in Exponent during the 3rd quarter valued at $60,000. Finally, Benjamin F. Edwards & Company Inc. grew its holdings in Exponent by 70.5% during the second quarter. Benjamin F. Edwards & Company Inc. now owns 873 shares of the business services provider's stock worth $83,000 after acquiring an additional 361 shares during the period. Institutional investors own 92.37% of the company's stock.
Insider Activity
In other news, Director Paul R. Johnston sold 14,000 shares of Exponent stock in a transaction on Wednesday, November 6th. The stock was sold at an average price of $104.60, for a total transaction of $1,464,400.00. Following the transaction, the director now owns 80,742 shares in the company, valued at approximately $8,445,613.20. The trade was a 14.78 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Carol Lindstrom sold 1,039 shares of the company's stock in a transaction on Monday, November 4th. The shares were sold at an average price of $96.32, for a total value of $100,076.48. Following the transaction, the director now directly owns 5,871 shares in the company, valued at $565,494.72. The trade was a 15.04 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 22,039 shares of company stock worth $2,291,286 over the last 90 days. 2.10% of the stock is owned by company insiders.
Analyst Ratings Changes
Separately, Truist Financial reiterated a "buy" rating and set a $120.00 price objective (up previously from $100.00) on shares of Exponent in a research report on Friday, July 26th.
Check Out Our Latest Research Report on EXPO
Exponent Stock Performance
Shares of NASDAQ:EXPO traded down $1.21 during midday trading on Friday, reaching $97.40. The company had a trading volume of 242,889 shares, compared to its average volume of 245,660. The company has a fifty day simple moving average of $107.23 and a two-hundred day simple moving average of $102.04. The firm has a market cap of $4.94 billion, a price-to-earnings ratio of 47.05 and a beta of 0.69. Exponent, Inc. has a 1-year low of $68.70 and a 1-year high of $115.75.
Exponent Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Friday, December 20th. Stockholders of record on Friday, December 6th will be given a $0.28 dividend. This represents a $1.12 annualized dividend and a dividend yield of 1.15%. The ex-dividend date of this dividend is Friday, December 6th. Exponent's dividend payout ratio (DPR) is currently 54.11%.
About Exponent
(
Free Report)
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.
Featured Articles
Before you consider Exponent, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exponent wasn't on the list.
While Exponent currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.